PostEra

PostEra is a modern biopharmaceutical company utilizing cutting-edge machine learning to accelerate the drug discovery process and bring new cures to patients. Their focus is on bridging the gap in medicinal chemistry, specifically addressing the time-consuming "Design-Make-Test" cycle. PostEra's proprietary platform, Proton, employs advanced AI techniques to optimize molecule design, synthesis, and testing, ultimately aiming to bring more effective and safer drug candidates to clinical trials faster.

PostEra collaborates with leading pharmaceutical companies like Pfizer and Amgen, leveraging their expertise and data to advance drug discovery programs. The company also pursues its own internal drug discovery pipeline, focusing on areas like women's health, fertility, and virology. PostEra's commitment to open science is evident in their involvement with the COVID Moonshot, a large-scale initiative aimed at developing patent-free antivirals to address global health challenges.

PostEra offers a remote work option for some roles, particularly in their business and general interest categories. This flexibility allows employees to work from home or any location they choose, providing a work-life balance that suits their needs.

PostEra is a modern biopharmaceutical company dedicated to accelerating drug discovery and bringing more cures to patients. They leverage advanced machine learning technology to close the design-make-test cycle of medicinal chemistry, enabling faster and more efficient development of new therapies. Their focus is on finding solutions for diseases through both internal drug discovery pipelines and collaborative co-discovery efforts with leading pharmaceutical companies.

PostEra fosters a collaborative and innovative culture, built on a shared passion for leveraging machine learning to accelerate drug discovery. The company values scientific curiosity, teamwork, and a drive to bring impactful cures to patients. This is reflected in their open-science initiatives, partnerships with leading pharmaceutical companies, and the diverse backgrounds of their team members. A commitment to transparency and the pursuit of groundbreaking research are central to their approach.